MedPath

Post mastectomy radiotherapy among patients with T1-T2 1-3 node positive disease. A retrospective cohort study

Conditions
Radiotherapy patients
C50
Malignant neoplasm of breast
Registration Number
DRKS00024402
Lead Sponsor
Aga Khan University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
755
Inclusion Criteria

The inclusion criteria were 1) all Breast Cancer patients who had Modified Radical Mastectomy with pathology result showing T1-T2 &1-3 positive nodes who did or did not receive PMRT. 2) Pathology report confirming negative margins. 3) Complete record of oestrogen receptor (ER), progesterone receptor (PR) and human epithelial growth factor receptor (HER-2) status. 4) Number of excised nodes after axillary dissection in double digits i.e. > 10 nodes.

Exclusion Criteria

Incomplete medical records.
Lost to follow up

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall Survival in patients who did or did not receive radiotherapy postmastectomy in early breast cancer.
Secondary Outcome Measures
NameTimeMethod
Disease free survival in patients who did or did not receive radiotherapy post mastectomy in early breast cancer.
© Copyright 2025. All Rights Reserved by MedPath